CUSIP: G11217117
What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G11217117:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q4 | 0 | $0 | -$135,176,980 | 0 | |
| 2023 Q3 | 12,479,806 | $135,176,980 | +$936,363 | $10.84 | 30 |
| 2023 Q2 | 12,409,248 | $132,110,962 | -$100,400,369 | $10.65 | 32 |
| 2023 Q1 | 22,095,858 | $230,673,906 | +$12,176,103 | $10.44 | 60 |
| 2022 Q4 | 20,800,614 | $213,298,218 | +$5,998,520 | $10.26 | 66 |
| 2022 Q3 | 20,088,733 | $201,743,000 | +$12,171,699 | $10.04 | 67 |
| 2022 Q2 | 19,286,449 | $192,795,000 | +$8,222,625 | $10.00 | 65 |
| 2022 Q1 | 17,574,000 | $173,634,000 | +$169,681,000 | $9.88 | 56 |